| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/24/2003 | WO2003060072A2 Recombinant polypeptides |
| 07/24/2003 | WO2003060071A2 Albumin fusion proteins |
| 07/24/2003 | WO2003060068A2 Oxa1p enhanced protein secretion |
| 07/24/2003 | WO2003060066A2 Nucleic acid delivery and expression |
| 07/24/2003 | WO2003060065A2 Adapter-directed display system |
| 07/24/2003 | WO2003060058A1 Petal-array support for use with microplates |
| 07/24/2003 | WO2003059952A1 Bispecific antibody dna constructs for intramuscular administration |
| 07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059949A2 A protein that mediates angiogenesis and tumour growth inhibition, its cdna, alone or in complex with an expression vector |
| 07/24/2003 | WO2003059945A2 Soluble recombinant protein production |
| 07/24/2003 | WO2003059944A2 Gb virus b based replicons and replicon enhanced cells |
| 07/24/2003 | WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 07/24/2003 | WO2003059938A1 Chromatin remodeling protein as a marker expressed by stromal progenitor cells |
| 07/24/2003 | WO2003059936A2 Phytophthora Infestans CDC 14 Phosphatase Gene, Protein and Methods of Use |
| 07/24/2003 | WO2003059935A2 Methods for purifying protein |
| 07/24/2003 | WO2003059934A2 Albumin fusion proteins |
| 07/24/2003 | WO2003059932A2 Methods of inducing or enhancing connective tissue repair |
| 07/24/2003 | WO2003059929A1 Heteroconfigurational polynucleotide and methods of use |
| 07/24/2003 | WO2003059928A1 Polynucleotide encoding an ap-2 domain transcription factor |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059923A2 Methods and compositions for generating a genetically modified animal using lentiviral vectors |
| 07/24/2003 | WO2003059516A1 Reaction vessel for carrying out array processes |
| 07/24/2003 | WO2003059396A1 Adiponectin gene therapy |
| 07/24/2003 | WO2003059395A2 Antisense compounds directed against human csf-1 |
| 07/24/2003 | WO2003059384A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 07/24/2003 | WO2003059374A2 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 07/24/2003 | WO2003059322A1 Efficient nucleic acid encapsulation into medium sized liposomes |
| 07/24/2003 | WO2003059292A2 Composition and method for maintaining non-enveloped viral vectors |
| 07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
| 07/24/2003 | WO2003059267A2 SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF |
| 07/24/2003 | WO2003059260A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 07/24/2003 | WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | WO2003059153A2 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |
| 07/24/2003 | WO2003059148A2 Gene expression profiles in stomach cancer |
| 07/24/2003 | WO2003059072A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | WO2003059054A1 Transgenic mouse with disrupted calcium ion channel alpha1b gene and production method thereof |
| 07/24/2003 | WO2003059053A2 Rabbit nuclear cloning method and uses thereof |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003045332A3 Methods and compositions for treating lesions of the respiratory epithelium |
| 07/24/2003 | WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 07/24/2003 | WO2003029291A3 Pegylated and diglycosylated erythropoietin |
| 07/24/2003 | WO2003022884A3 Methods for construction and screening of libraries of chemokine variants |
| 07/24/2003 | WO2003022032A3 Method for increasing stress tolerance in plants |
| 07/24/2003 | WO2003020927A3 Creation of artificial internal ribosome entry site (ires) elements |
| 07/24/2003 | WO2003018612A3 Extracellular messengers |
| 07/24/2003 | WO2003016495A3 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein |
| 07/24/2003 | WO2003011895A3 Compositions and methods for modulation of immune responses |
| 07/24/2003 | WO2003010289A3 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis |
| 07/24/2003 | WO2003006661A3 Transgenic plants expressing cobalamin binding proteins |
| 07/24/2003 | WO2003006651A3 Vascular tissue preferred promoters |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2003004669A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression |
| 07/24/2003 | WO2003004663A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 07/24/2003 | WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 07/24/2003 | WO2002102839A3 Novel g-protein coupled receptors and dna sequences thereof |
| 07/24/2003 | WO2002099057A3 Sams modifiers of the p53 pathway and methods of use |
| 07/24/2003 | WO2002090531A3 Peptidylarginine deiminase 6 |
| 07/24/2003 | WO2002090371A3 Method for preparative production of long nucleic acids by pcr |
| 07/24/2003 | WO2002088358A3 Human fibroblast growth factor-related compositions |
| 07/24/2003 | WO2002088310A3 Cobra gene and uses thereof |
| 07/24/2003 | WO2002086107A3 A method for differentiating stem cells into insulin-producing cells |
| 07/24/2003 | WO2002079439A3 TRANSGENIC MICE CONTAINING mGluR7 METABOTROPIC GLUTAMATE RECEPTOR GENE DISRUPTIONS |
| 07/24/2003 | WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 07/24/2003 | WO2002070645A3 Functional surface display of polypeptides |
| 07/24/2003 | WO2002066640A3 Zinc finger binding domains for nucleotide sequence ann |
| 07/24/2003 | WO2002062846A3 Method and apparatus for the production of antigens and uses thereof |
| 07/24/2003 | WO2002061127A3 Arrayed polynucleotides and their use in genome analysis |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002059338A3 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 07/24/2003 | WO2002059323A3 Aminoacyl trna synthetases |
| 07/24/2003 | WO2002059300A3 Double-stranded rna-mediated gene suppression |
| 07/24/2003 | WO2002057480A3 Cell-proliferative disorder treatments using cre decoy oligomers, bcl-2 antisense and hybrid oligomers |
| 07/24/2003 | WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/24/2003 | WO2002053719A3 Cytoskeleton-associated proteins |
| 07/24/2003 | WO2002052018A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/24/2003 | WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same |
| 07/24/2003 | WO2002050276A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002050275A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002048676A9 Multiple array system for integrating bioarrays |
| 07/24/2003 | WO2002044417A3 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 07/24/2003 | WO2002044355A3 Protozoan expression systems for lysosomal storage disease genes |
| 07/24/2003 | WO2002040685A9 Vectors for conditional gene inactivation |
| 07/24/2003 | WO2002037957A3 Transgenic mice containing perk protein kinase gene disruptions |
| 07/24/2003 | WO2002036791A3 Nucleus export reporter system |
| 07/24/2003 | WO2002033087A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002030457A9 Microbes having an attenuating mutation comprising a transcription terminator |
| 07/24/2003 | WO2002014550A3 Transcription factor target gene discovery |
| 07/24/2003 | WO2002012562A3 Haplotypes of the pla2g1b gene |
| 07/24/2003 | WO2002006537A3 Methods of identifying renal protective factors |
| 07/24/2003 | WO2001091548A3 Mice heterozygous for wfs1 gene as mouse models for depression |
| 07/24/2003 | US20030140382 Process for generating genetically modified pearl millet through agrobacterium and biolistic transformation |
| 07/24/2003 | US20030140381 Genes and regulatory DNA sequences associated with stress-related gene expression in plants and methods of using the same |
| 07/24/2003 | US20030140380 Amine oxidase stress-related polypeptides and methods of use in plants |
| 07/24/2003 | US20030140378 Antirrhinum majus/arabidopsis nucleotide sequences coding and expressing centroradialis (CEN)/terminal flower-1 (TF1) genes in apical meristems; controlling fruit propagation; papermaking |
| 07/24/2003 | US20030140377 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 07/24/2003 | US20030140376 Optimized t-dna transfer and vectors therefor |
| 07/24/2003 | US20030140375 Nucleotide sequences coding R-resistant genes/proteins for generating disease resistant plants; animal feeds |